Prednisolone and Mycobacterium indicus pranii in Tuberculous Pericarditis BM Mayosi, M Ntsekhe, J Bosch, S Pandie, H Jung, F Gumedze, J Pogue, ... New England Journal of Medicine 371 (12), 1121-1130, 2014 | 302 | 2014 |
Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study F van Gemert, B Kirenga, N Chavannes, M Kamya, S Luzige, P Musinguzi, ... The Lancet Global Health 3 (1), e44-e51, 2015 | 236 | 2015 |
Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis KP Fennelly, EC Jones-López, I Ayakaka, S Kim, H Menyha, B Kirenga, ... American journal of respiratory and critical care medicine 186 (5), 450-457, 2012 | 194 | 2012 |
Association between household air pollution exposure and chronic obstructive pulmonary disease outcomes in 13 low-and middle-income country settings T Siddharthan, MR Grigsby, D Goodman, M Chowdhury, A Rubinstein, ... American journal of respiratory and critical care medicine 197 (5), 611-620, 2018 | 164 | 2018 |
Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control BJ Kirenga, W Ssengooba, C Muwonge, L Nakiyingi, S Kyaligonza, ... BMC public health 15, 1-7, 2015 | 141 | 2015 |
Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective … SG Mfinanga, BJ Kirenga, DM Chanda, B Mutayoba, T Mthiyane, G Yimer, ... The Lancet infectious diseases 14 (7), 563-571, 2014 | 132 | 2014 |
Elucidating emergence and transmission of multidrug-resistant tuberculosis in treatment experienced patients by whole genome sequencing TG Clark, K Mallard, F Coll, M Preston, S Assefa, D Harris, S Ogwang, ... PloS one 8 (12), e83012, 2013 | 95 | 2013 |
Long term complications after completion of pulmonary tuberculosis treatment: a quest for a public health approach J Chakaya, B Kirenga, H Getahun Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 3, 10-12, 2016 | 85 | 2016 |
Predictors and outcomes of mycobacteremia among HIV-infected smear-negative presumptive tuberculosis patients in Uganda L Nakiyingi, W Ssengooba, D Nakanjako, D Armstrong, M Holshouser, ... BMC infectious Diseases 15, 1-8, 2015 | 51 | 2015 |
Treatment outcomes of new tuberculosis patients hospitalized in Kampala, Uganda: a prospective cohort study BJ Kirenga, J Levin, I Ayakaka, W Worodria, N Reilly, F Mumbowa, ... PLoS One 9 (3), e90614, 2014 | 50 | 2014 |
Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2× 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone … BM Mayosi, M Ntsekhe, J Bosch, J Pogue, F Gumedze, M Badri, H Jung, ... American heart journal 165 (2), 109-115. e3, 2013 | 46 | 2013 |